海翔药业 (002099)

Zhejiang Hisoar Pharmaceutical Co.,Ltd.

ASZ

Tags

Weight Loss DrugsDisperse DyesInnovative DrugsPharmaceutical ManufacturingBuyback PlansLow-Profit StocksBiological VaccinesHepatitis ConceptMargin Trading and Securities Lending

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 161871.53
  • Circulating A-Shares(W): 161569.79
  • Earnings Per Share(RMB): 0.0000
  • Net Assets Per Share(RMB): 3.1632
  • Operating Revenue(W RMB): 136658.59
  • Total Profit(W RMB): 1858.40
  • Net Profit Attributable to Parent(W RMB): 729.03
  • Net Profit Growth Rate(%): -39.15
  • Weighted Return on Equity(%): 0.1400
  • Operating Cash Flow Per Share(RMB): 0.0110
  • Undistributed Profit Per Share(RMB): 0.2981
  • Capital Reserve Per Share(RMB): 1.8020

2. Main Business

The main business covers:

  • Pharmaceutical Manufacturing
  • Dye Full Industry Chain

3. Company Basic Information

  • Company Name: Zhejiang Hisoar Pharmaceutical Co., Ltd.
  • Listing Date: 2006-12-26
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 100 Waisha Branch Road, Jiaojiang District, Taizhou City, Zhejiang Province, China
  • Website: www.hisoar.com
  • Company Profile：The company was restructured into Zhejiang Hisoar Pharmaceutical Chemical Co., Ltd. with the approval of the Zhejiang Provincial People's Government's Leading Group for Enterprise Listing. It was registered and established on May 13, 2004, at the Zhejiang Provincial Administration for Industry and Commerce, with a registered capital of 80 million yuan. On June 24, 2004, the company was renamed Zhejiang Hisoar Pharmaceutical Co., Ltd.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Zhejiang Donggang Industrial Co., Ltd. General Legal Person 52398.26 32.43
2 Zhejiang Hisoar Pharmaceutical Co., Ltd. - Phase I Employee Stock Ownership Plan Asset Management Plan 2952.37 1.83
3 Shanghai Chengrui Investment Management Co., Ltd. - Chengrui Zhengqian No. 36 Private Securities Investment Fund Private Securities Investment Fund 2700.00 1.67
4 Hong Kong Securities Clearing Company Ltd. Northbound Capital 1093.41 0.68
5 Southern China Securities 1000 Exchange Traded Open-End Index Securities Investment Fund Fund 1035.83 0.64

5. Concept Sectors

  • Biological Vaccine
  • Disperse Dye
  • Hepatitis Concept
  • Innovative Drug
  • Weight Loss Drug
  • Margin Trading & Securities Lending
  • Low-Profit Stock
  • Share Repurchase Plan
  • Consecutive Losses

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information